Literature DB >> 28729254

Finished Whole-Genome Sequences of Clostridium butyricum Toxin Subtype E4 and Clostridium baratii Toxin Subtype F7 Strains.

Jessica L Halpin1, Karen Hill2, Shannon L Johnson2, David Carlton Bruce2, T Brian Shirey3, Janet K Dykes3, Carolina Lúquez3.   

Abstract

Clostridium butyricum and Clostridium baratii species have been known to produce botulinum toxin types E and F, respectively, which can cause botulism, a rare but serious neuroparalytic disease. Here, we present finished genome sequences for two of these clinically relevant strains.
Copyright © 2017 Halpin et al.

Entities:  

Year:  2017        PMID: 28729254      PMCID: PMC5522921          DOI: 10.1128/genomeA.00375-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Some rare strains of Clostridium butyricum and Clostridium baratii carry the botulinum neurotoxin gene cluster (1–8). Botulinum toxin causes a rare but serious disease that produces a descending flaccid paralysis that can result in death if not treated (9). C. baratii type F strain CDC51267 and C. butyricum type E strain CDC51208 were sequenced by Illumina and PacBio. A hybrid assembly method was utilized, and the sequences from both isolates were assembled using Velvet 1.2.08, HGAP 3, and Phrap 4.24. The coverages for C. baratii isolate CDC51267 were 357× by PacBio and 342× by Illumina. The coverages for C. butyricum isolate CDC51208 were 52.6× by PacBio and 319× by Illumina. C. baratii serotype F strain CDC51267 was isolated from a food specimen associated with a foodborne botulism outbreak. The finished genome includes one plasmid, pNPD11_1 (accession no. CP014203), of 120,667 bp, with 25.3% G+C content and 119 coding regions. The chromosome (accession no. CP014204) size is 3,091,050 bp, with 28.4% GC content and 2,885 identified coding regions. The toxin gene was determined to be subtype F7 and was found within the plasmid. C. butyricum serotype E strain CDC51208 was isolated from an infant botulism case. The resulting finished genome includes two plasmids of 9,567 bp (pNPD4_1, accession no. CP013240) and 820,516 bp (pNPD4_2, accession no. CP13238). These plasmids consist of 26.8% and 28.2% G+C content, as well as 8 and 763 coding sequences (CDSs), respectively. The chromosome (accession no. CP013239) has 3,809,831 bp, 28.8% G+C content, and 3,334 identified coding regions. The toxin gene was determined to be subtype E4 and was found within the pNPD4_2 plasmid.

Accession number(s).

These finished sequences have been deposited in GenBank, with accession numbers CP014204 and CP014203 for C. baratii strain CDC51267, and accession numbers CP013238, CP013239, and CP013240 for C. butyricum strain CDC51208.
  9 in total

1.  Laboratory Investigation of the First Case of Botulism Caused by Clostridium butyricum Type E Toxin in the United States.

Authors:  Janet K Dykes; Carolina Lúquez; Brian H Raphael; Loretta McCroskey; Susan E Maslanka
Journal:  J Clin Microbiol       Date:  2015-08-05       Impact factor: 5.948

2.  A cluster of three cases of botulism due to Clostridium baratii type F, France, August 2015.

Authors:  Hélène Tréhard; Isabelle Poujol; Christelle Mazuet; Quentin Blanc; Yves Gillet; Frédérique Rossignol; Michel-Robert Popoff; Nathalie Jourdan Da Silva
Journal:  Euro Surveill       Date:  2016

Review 3.  Clinical spectrum of botulism.

Authors:  M Cherington
Journal:  Muscle Nerve       Date:  1998-06       Impact factor: 3.217

4.  Botulism due to Clostridium baratii type F toxin.

Authors:  Sydney M Harvey; Joan Sturgeon; David E Dassey
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Two cases of adult botulism caused by botulinum neurotoxin producing Clostridium baratii.

Authors:  George E Hannett; Joshua K Schaffzin; Stephen W Davis; Maureen P Fage; Dianna Schoonmaker-Bopp; Nellie B Dumas; Kimberlee A Musser; Christina Egan
Journal:  Anaerobe       Date:  2014-10-18       Impact factor: 3.331

6.  First report worldwide of an infant botulism case due to Clostridium botulinum type E.

Authors:  Carolina Lúquez; Janet K Dykes; Patricia A Yu; Brian H Raphael; Susan E Maslanka
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

7.  Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism.

Authors:  J D Hall; L M McCroskey; B J Pincomb; C L Hatheway
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

8.  Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy.

Authors:  P Aureli; L Fenicia; B Pasolini; M Gianfranceschi; L M McCroskey; C L Hatheway
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

9.  Notes from the field: infant botulism caused by Clostridium baratii type F - Iowa, 2013.

Authors:  Amaran Moodley; Patricia Quinlisk; Ann Garvey; Nicholas Kalas; Jason R Barash; Jessica M Khouri
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-04-17       Impact factor: 17.586

  9 in total
  4 in total

1.  The Distinctive Evolution of orfX Clostridium parabotulinum Strains and Their Botulinum Neurotoxin Type A and F Gene Clusters Is Influenced by Environmental Factors and Gene Interactions via Mobile Genetic Elements.

Authors:  Theresa J Smith; Charles H D Williamson; Karen K Hill; Shannon L Johnson; Gary Xie; Fabrizio Anniballi; Bruna Auricchio; Rafael A Fernández; Patricia A Caballero; Paul Keim; Jason W Sahl
Journal:  Front Microbiol       Date:  2021-02-26       Impact factor: 5.640

2.  Comparative Genomics of Clostridium baratii Reveals Strain-Level Diversity in Toxin Abundance.

Authors:  Claudia Silva-Andrade; Alberto J Martin; Daniel Garrido
Journal:  Microorganisms       Date:  2022-01-20

3.  Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins.

Authors:  Andrea Pathe-Neuschäfer-Rube; Frank Neuschäfer-Rube; Gerald Haas; Nina Langoth-Fehringer; Gerhard Paul Püschel
Journal:  Toxins (Basel)       Date:  2018-09-05       Impact factor: 4.546

4.  Discrimination of the Activity of Low-Affinity Wild-Type and High-Affinity Mutant Recombinant BoNT/B by a SIMA Cell-Based Reporter Release Assay.

Authors:  Frank Neuschäfer-Rube; Andrea Pathe-Neuschäfer-Rube; Gerhard P Püschel
Journal:  Toxins (Basel)       Date:  2022-01-17       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.